SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001047469-18-002761
Filing Date
2018-04-12
Accepted
2018-04-12 17:21:43
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3/A a2235088zs-3a.htm S-3/A 160121
2 EX-5.1 a2235088zex-5_1.htm EX-5.1 9365
3 EX-23.1 a2235088zex-23_1.htm EX-23.1 3547
4 G349475.JPG g349475.jpg GRAPHIC 18430
5 G768759.JPG g768759.jpg GRAPHIC 5907
6 G454752.JPG g454752.jpg GRAPHIC 15457
7 G566233.JPG g566233.jpg GRAPHIC 17257
8 G346302.JPG g346302.jpg GRAPHIC 3823
9 G998995.JPG g998995.jpg GRAPHIC 21661
  Complete submission text file 0001047469-18-002761.txt   288595
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-219736 | Film No.: 18752733
SIC: 2834 Pharmaceutical Preparations